Medical advances and racial/ethnic disparities in cancer survival

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 10, 2009, Pages 2701-2708

  Tehranifar, Parisa ^a   Neugut, Alfred I ^a,b   Phelan, Jo C ^a   Link, Bruce G ^a   Liao, Yuyan ^a   Desai, Manisha ^a   Terry, Mary Beth ^a,b  

^a Columbia University Mailman School of Public Health ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; AMERICAN INDIAN; ARTICLE; CANCER SURVIVAL; CAUCASIAN; ESKIMO; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; HEALTHCARE DISPARITIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 70350116831     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0305     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004;101:3-27.
3. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US White and minorities. Arch Intern Med 2002;162:1985-1993
4. Singh GK, Miller BA, Hankey BF, Edwards BK. Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI Cancer Surveillance Monograph Series, Number 4. Bethesda, MD, 2007.
5. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C. Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA 2005;294:1765-1772 (Pubitemid 41434622)
6. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 2004;57:597-609.
7. Gomez SL, O'Malley CD, Stroup A, Shema SJ, WA S. Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer 2007;16:193. (Pubitemid 351234157)
8. Virnig BA, Baxter NN, Habermann EB, Feldman RD, Bradley CJ. A matter of race: early-versus late-stage cancer diagnosis. Health Aff 2009;28:160-168
9. Phelan JC, Link BG. Controlling disease and creating disparities: a fundamental cause perspective. J Gerontol 2005;60B:27-33.
10. Phelan JC, Link BG, Diez-Roux A, Kawachi I, Levin B. "Fundamental causes" of social inequalities in mortality: a test of the theory. J Health Soc Behav 2004;45:265-285
11. Henson DE, Ries LA. The relative survival rate. Cancer 1995;76:1687-1688
12. Surveillance, Epidemiology and End Results (SEER) Program. National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch. Available from: (http://seer.cancer.gov/seerstat/index.html).
13. Hosmer DW, Lemeshow S, May S. Applied survival analysis: regression modeling of time-to-event data. 2nd ed. Hoboken (NJ): John Wiley and Sons; 2008.
14. Chien C, Morimoto LM, Tom J, Li CI. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer 2005;104:629-639 (Pubitemid 41022822)
15. Doubeni CA, Field TS, Buist DS, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 2007;109:612-620
16. Abraido-Lanza AF, Dohrenwend BP, Ng-Mak DS, Turner KB. The Latino mortality paradox: a test of the "Salmon Bias" and Healthy Migrant hypotheses. Am J Public Health 1999;89:1543-1548
17. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-8442.
18. Jemal A, Thun MJ, Ward EE, Henley SJ, Cokkinides VE, Murray TE. Mortality from leading causes by education and race in the United States, 2001. Am J Prev Med 2008;34:1-8.
19. Glied S, Lleras-Muney A. Technological innovation and inequality in health. Demography 2008;45:741-761
20. Link BG, Northridge ME, Phelan JC, Ganz ML. Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status. Milbank Q 1998;76:375-402.
21. Kogevinas M, Marmot MG, Fox AJ, Goldblatt PO. Socioeconomic differences in cancer survival. J Epidemiol Community Health 1991;45: 216-219
22. DeLancey JO, Thun MJ, Jemal A, Ward EM. Recent trends in Black- White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev 2008;17:2908-2912
23. Albains KS, Unger JM, Crowley JJ, Coltman Ca, Hershman DL. Racial disparities in cancer survival among randomized clinical trial patients of the Southwest Oncology Group. J Natl Cancer Inst 2009;101:984-992
24. Ward E, Jemal A, Cokkinides V, et al. Cancer Disparities by race/ ethnicity and socioeconomic status. CA Cancer J Clin 2004;54:78-93. (Pubitemid 38519418)
25. Tripathi RT, Heilbrun LK, Jain V, Vaishampayan U. Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma. Urology 2006;68:296-301. (Pubitemid 44175498)
26. Field TS, Buist DS, Doubeni C, et al. Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr 2005;35:88-95.
27. Vargas RB, Ryan GW, Jackson CA, Rodriguez R, Freeman HP. Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer 2008;113:426-433
28. Clegg LX, Reichman ME, Hankey BF, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 2007;18:177-187